IGEM:Paris Bettencourt 2012/Notebooks/Delay group: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
No edit summary
 
(10 intermediate revisions by 4 users not shown)
Line 1: Line 1:
{| border = "1" width="100%"
{| border = "1" width="100%"  
  ! [[IGEM:Paris_Bettencourt_2012/Notebook/| Notebook]]
  ! [[IGEM:Paris_Bettencourt_2012/Notebooks | Notebooks]]
  ! [[IGEM:Paris_Bettencourt_2012/Design/| Design]]
  ! [[IGEM:Paris_Bettencourt_2012/Design | Design]]
  ! [[IGEM:Paris_Bettencourt_2012/Roadmap | Roadmap]]
  ! [[IGEM:Paris_Bettencourt_2012/Roadmap | Roadmap]]
  ! [[Meetings and to-dos]]
  ! [[Meetings and to-dos]]
Line 8: Line 8:
  ! [[IGEM:Paris_Bettencourt_2012/Previous_Biosafety_iGEM_Projects | Previous Biosafety iGEM projects]]
  ! [[IGEM:Paris_Bettencourt_2012/Previous_Biosafety_iGEM_Projects | Previous Biosafety iGEM projects]]
|}
|}
 
[[IGEM:Paris_Bettencourt_2012/Notebooks/Delay_group/Lab_notes | Lab notes]]
 
 
 
<center>'''Delay group'''</center>
<center>'''Delay group'''</center>
----
----
Line 19: Line 16:
Here we report the idea we have, and how we could make them real.
Here we report the idea we have, and how we could make them real.


===Alginate beads===
=Alginate beads=
Here, we would place alginate beads, with controlled alginate matrix size into the capsule. The alginate beads contains theophylline, that would act as an activator of a [http://en.wikipedia.org/wiki/Riboswitch| riboswitch] that would repress gene expression [1]. This riboswitch would be fused into the 5'-UTR of the gene we want to repress (see figure 1). That gene would be one of the [http://en.wikipedia.org/wiki/Colicin| colicin] gene, that can diffuse and kill other ''Enterobacteriaceae''. The colicine gene is under Rpos promoter which is activated when bacteria is on stationary phase. So, bacteria  will die on stationary phase and when theophylline is under a certain threshold, thanks to its diffusion through beads and capsule.
Here, we would place alginate beads, with controlled alginate matrix size into the capsule. The alginate beads contains theophylline, that would act as an activator of a [http://en.wikipedia.org/wiki/Riboswitch riboswitch] that would repress gene expression [1]. On of our options is to deliver theophylline through bits of complex sugars that would be the carbon source of our bacteria. The riboswitch would be fused into the 5' end of the gene we want to repress (see figure 1). That gene would be one of the [http://en.wikipedia.org/wiki/Colicin colicin] gene, that can diffuse and kill other ''Enterobacteriaceae''. The riboswitch will be translated, and thus we need to ensure that it will not affect the function of the protein. The colicine gene is under Rpos promoter which is activated when bacteria is on stationary phase (e.g. YiaGp). So, bacteria  will die on stationary phase and when theophylline is under a certain threshold, thanks to its diffusion through beads and capsule.
 
However, we need to ensure that the expression of this toxin protein is very repressed and that it will not affect the fitness of the bacteria as long as it is in stationary phase with theophylline.
If possible, we would like to try to replace the nuclease domain of the colicin gene with a restriction enzyme domain to target exclusively the synthetic genes carried by the plasmid.
[[Image:Theophuline_riboswitch.png|center|500px]]
[[Image:Theophuline_riboswitch.png|center|500px]]
<center>Figure 1 : Theophylline riboswitch, adapted from [1]</center>
<center>Figure 1 : Theophylline riboswitch, adapted from [1]</center>


== References ==  
= References =
1. Topp, S. & Gallivan, J.P. Riboswitches in unexpected places -€” A synthetic riboswitch in a protein coding region. RNA journal 2498-2503 (2008) [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2590966/| Paper]
1. Topp, S. & Gallivan, J.P. Riboswitches in unexpected places -€” A synthetic riboswitch in a protein coding region. RNA journal 2498-2503 (2008) [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2590966/| Paper]
=sRNA control=
To achieve a strong repression of the colicin expression (and avoid the problems linked to its toxicity for the cell), we want to couple a repression at the level of the promoter (yiaGp is transcribed only in stationnary phase) to a post-trancriptional control using sRNAs. To do so, we will adapt a previously decribed system [1]. We hope to build and characterize the following design.
[[Image:Capture_d’écran_2012-07-19_à_15.41.23.png|center|600px]]
We will use the leader sequence of OmpF (a porine). The authors of the article found a post-translational repression of up to 145-fold.
= References =
1. Sharma, V., Yamamura, A., & Yokobayashi, Y. (2012). Engineering Artificial Small RNAs for Conditional Gene Silencing in Escherichia coli, 6-13.
[http://pubs.acs.org/doi/abs/10.1021/sb200001q| Paper]

Latest revision as of 06:57, 19 July 2012

Notebooks Design Roadmap Meetings and to-dos Protocols Bibliography Previous Biosafety iGEM projects

Lab notes

Delay group

The aim of that subproject is to find a way to launch the destruction of either the construction or the organism after a certain laps of time.

Here we report the idea we have, and how we could make them real.

Alginate beads

Here, we would place alginate beads, with controlled alginate matrix size into the capsule. The alginate beads contains theophylline, that would act as an activator of a riboswitch that would repress gene expression [1]. On of our options is to deliver theophylline through bits of complex sugars that would be the carbon source of our bacteria. The riboswitch would be fused into the 5' end of the gene we want to repress (see figure 1). That gene would be one of the colicin gene, that can diffuse and kill other Enterobacteriaceae. The riboswitch will be translated, and thus we need to ensure that it will not affect the function of the protein. The colicine gene is under Rpos promoter which is activated when bacteria is on stationary phase (e.g. YiaGp). So, bacteria will die on stationary phase and when theophylline is under a certain threshold, thanks to its diffusion through beads and capsule. However, we need to ensure that the expression of this toxin protein is very repressed and that it will not affect the fitness of the bacteria as long as it is in stationary phase with theophylline. If possible, we would like to try to replace the nuclease domain of the colicin gene with a restriction enzyme domain to target exclusively the synthetic genes carried by the plasmid.

Figure 1 : Theophylline riboswitch, adapted from [1]

References

1. Topp, S. & Gallivan, J.P. Riboswitches in unexpected places -€” A synthetic riboswitch in a protein coding region. RNA journal 2498-2503 (2008) Paper

sRNA control

To achieve a strong repression of the colicin expression (and avoid the problems linked to its toxicity for the cell), we want to couple a repression at the level of the promoter (yiaGp is transcribed only in stationnary phase) to a post-trancriptional control using sRNAs. To do so, we will adapt a previously decribed system [1]. We hope to build and characterize the following design.

We will use the leader sequence of OmpF (a porine). The authors of the article found a post-translational repression of up to 145-fold.

References

1. Sharma, V., Yamamura, A., & Yokobayashi, Y. (2012). Engineering Artificial Small RNAs for Conditional Gene Silencing in Escherichia coli, 6-13. Paper